|
May 23
|
3 Low-Volatility Stocks Walking a Fine Line
|
|
May 22
|
Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025
|
|
Apr 24
|
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
|
|
Apr 24
|
Exact Sciences (EXAS): Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside Potential
|
|
Apr 24
|
2 Reasons to Like EXAS (and 1 Not So Much)
|
|
Apr 23
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
|
Apr 22
|
Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test
|
|
Apr 7
|
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)
|
|
Apr 1
|
Exact Sciences Schedules First Quarter 2025 Earnings Call
|
|
Mar 31
|
Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening
|
|
Mar 3
|
Exact Sciences Corporation (EXAS): Among the Cash-Rich Mid Cap Stocks to Buy Now
|
|
Feb 25
|
Exploring Three High Growth Tech Stocks In The United States
|
|
Feb 24
|
2 Stocks Down 59% and 34% to Buy and Hold
|
|
Feb 24
|
Exact Sciences to Participate in March Investor Conferences
|
|
Feb 21
|
Exact Sciences Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 20
|
Why Exact Sciences (EXAS) Shares Are Trading Lower Today
|
|
Feb 20
|
Q4 2024 Exact Sciences Corp Earnings Call
|
|
Feb 20
|
EXAS Q4 Loss Narrower Than Expected, Stock Falls, Revenues Up Y/Y
|
|
Feb 20
|
Exact Sciences Corp (EXAS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
Feb 20
|
Exact Sciences (EXAS) Q4 2024 Earnings Call Transcript
|